Caroline Fortier

Caroline Fortier is the founder of AurKa Pharma, Inc. Current positions include Chief Executive Officer at ImmunoRx Pharma, Inc., Chief Executive Officer & Director at Société Générale de Promotion & de Financement Immobiliers SA, Chief Executive Officer at Esperas Pharma Inc. since 2015, Chief Executive Officer at T7 Therapeutics, Inc. since 2021, and Managing Director at Sogeprom Partenaires SAS. Former positions include President & Chief Executive Officer at Neokimia, Inc., Chief Executive Officer at GLWL Research, Inc., Chief Executive Officer at PRCL Research Inc., and Vice President-Corporate Development at Genizon Biosciences, Inc. Education includes a doctorate from Université Laval.